webinars
Stay Up-to-Date with Oncology Webinars
Members receive the webinar invites directly to their email.
If you are not receiving them, please reach out to contact@ncoda.org
Thursday | January 23 | 2 pm EST
Transplant Ineligible Newly Diagnosed Multiple Myeloma
Jeanine Ewing, PharmD, BCOP | Florida Cancer Specialists & Research Institute
Gain insight into isatuximab’s FDA-approved uses, mechanism of action, and essential considerations for dosing, safety, and monitoring. Explore the benefits of quad therapy with Isa-VRd compared to triplet therapy with VRd.
Metastatic Hormone-Sensitive Prostate Cancer
Karl J. D’Silva, MD | Bayer
Review metastatic hormone-sensitive prostate cancer, gain insights into darolutamide use, and explore findings from the ARASENS and PEACE-1 trials.
505(b)(2) FDA Drug Approval Pathway
Darrell Connor, MHA, FWSPA, PharmDc| Creighton University School of Pharmacy
Gain a comprehensive understanding of the FDA’s drug approval process, including the 505(b)(2) pathway, and recognize the advantages and challenges associated with this 505(b)(2) drug approval pathway.
Wednesday | January 29 | 1 pm EST
Hyunseok Kang, MD | University of California San Francisco
Shirin Khorashadi, PharmD, APh, BCOP | Univerity of California Los Angeles
Did you miss a webinar?
Not to worry! NCODA members can view recordings of the live webinars through our member portal, NCODA CONNECT.
*If you are a member and need assistance in logging into your NCODA CONNECT account, please reach out to contact@ncoda.org. Webinar recordings are available within 7 days after the live presentation.
November 2024 International Monthly Webinar | Thursday, November 21
Addressing the Unmet Need in Gastric and Gastroesophageal Junction (GEJ) Cancer with Zolbetuximab-clzb | Tuesday, November 19
OPTA November 2024 Webinar | Thursday, November 13
Zanubrutinib in CLL/SLL | Thursday, November 14
Understanding Prostate Cancer in Veterans | Tuesday, November 12
Vorasidenib: First mIDH1/2 Inhibitor for Grade 2 Gliomas with IDH1/2 Mutations | Tuesday, November 5
Navigating the IV Fluids Shortage | Tuesday, October 29
RESONATE-2: Primary and Long-Term Analysis of Ibrutinib Including Dose Modifications for Adverse Reactions | Wednesday, October 16
OPTA Special Presentation: Leukemia & Lymphoma Society | Tuesday, September 24
Zanubrutinib in Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) | Thursday, October 10
Management of Oncologic Dermatologic Toxicities | Tuesday, October 15
Nursing Community Gathering | Friday, October 11
October 2024 International Monthly Webinar | Thursday, October 17
Clinical Overview of Cabozantinib | Wednesday, October 2
September 2024 International Monthly Webinar | Thursday, September 19
Zanubrutinib in CLL or SLL | Tuesday, September 17
Become a member to access weekly live webinars. Membership is complimentary and provides access to additional resources and NCODA International Meetings.
RESOURCES
Cost Avoidance Waste Tracker
PQI in Action
OCE Sheets
IVE Sheets
Treatment Support Kits
PQI Podcast
Members
Member Resources
OPTA
Committees
Member Login
Events
Webinars
Spring Forum
Oncology Institute
PSO Annual Meeting
Fall Summit
315-655-4640
P.O. Box 468
Cazenovia, NY 13035